EX-32.2 7 ex32-2.htm CERTIFICATE OF CHIEF FINANCIAL OFFICER

TherapeuticsMD, Inc. 10-K

Exhibit 32.2

Section 1350 Certification of Chief Financial Officer

In connection with the Annual Report of TherapeuticsMD, Inc. (the "Company") on Form 10-K for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Daniel A. Cartwright, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 12, 2015 | /s/ Daniel A. Cartwright
| Name: Daniel A. Cartwright Title: Chief Financial Officer